India's Pharmaceutical Exports

Country Profile

Trinidad and Tobago

Trinidad and Tobago is an emerging destination for Indian pharmaceutical exports — $17.9M in FY 2025–26, with 1.7× growth over the past decade. Medicines accounts for 94% of shipments, with vaccines contributing $329K. The compound annual growth rate since FY2016 stands at 5.5%.

🇹🇹 $17.9M · 1.7× growth since FY2016 · 5.5% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$17.9M
Exports FY2025–26 DGCIS
1.7×
Growth FY2016→2026
5.5%
CAGR FY2016→2026
94%
Medicines Share
4
Product Categories Supplied
Trinidad and Tobago is an emerging destination for Indian pharmaceutical exports — $17.9M in FY 2025–26, with 1.7× growth over the past decade. Medicines accounts for 94% of shipments, with vaccines contributing $329K. The compound annual growth rate since FY2016 stands at 5.5%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $16.7M (93.5%) Traditional & Herbal $464K (2.6%) Surgical & Hospital Supplies $360K (2.0%) Vaccines $329K (1.8%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Trinidad and Tobago in the RBI overseas direct investment dataset (2011–2026).